galactosamine has been researched along with transforming growth factor alpha in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartlett, MH; Brown, PI; Fausto, N; FitzGerald, MJ; Webber, EM | 1 |
Chang, MF; Chang, MH; Chen, HL; Chen, YH; Chien, CS; Yu, CH | 1 |
Xiao, WZ; Zhang, L | 1 |
3 other study(ies) available for galactosamine and transforming growth factor alpha
Article | Year |
---|---|
Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Drug Interactions; ErbB Receptors; Galactosamine; Hepatectomy; Hepatocyte Growth Factor; Liver; Liver Regeneration; Male; Rats; Rats, Inbred Strains; RNA, Messenger; Transforming Growth Factor alpha | 1993 |
Impaired hepatocyte regeneration in acute severe hepatic injury enhances effective repopulation by transplanted hepatocytes.
Topics: Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Hepatic Stellate Cells; Hepatocyte Growth Factor; Hepatocytes; Liver Failure, Acute; Liver Regeneration; Male; Matrix Metalloproteinase 2; Pyrrolizidine Alkaloids; Rats; Rats, Inbred F344; Transforming Growth Factor alpha; Up-Regulation | 2009 |
Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice.
Topics: Acute Disease; Animals; Apoptosis; Caspases; Disease Models, Animal; Galactosamine; Hepatitis; Hepatocytes; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Piperidines; Receptors, Adiponectin; Transforming Growth Factor alpha | 2019 |